COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,140 Articles (22,693 medRxiv, 8,447 bioRxiv)

Most recent first Previous |  Page 1983: Articles 19821-19830  | Next

A Selective Increase in OC Symptoms is Driving Information Seeking and Guideline Adherence During the Covid-19 Pandemic
Loosen, A. M., Skvortsova, V., Hauser, T. U.
10.1101/2020.12.08.20245803 — Posted: 2020-12-09
Neighbourhood-level Racial/Ethnic and Economic Inequities in COVID-19 Burden Within Urban Areas in the US and Canada
Saha, S., Feldman, J. M.
10.1101/2020.12.07.20241018 — Posted: 2020-12-09
The Impacts of Testing Cadence, Mode of Instruction, and Student Density on Fall 2020 COVID-19 Rates On Campus
Stubbs, C. W., Springer, M., Thomas, T. S.
10.1101/2020.12.08.20244574 — Posted: 2020-12-09
A novel multi-omics-based identification of symptoms, comorbid conditions, and possible long-term complications in COVID-19
Barh, D., Tiwari, S., Andrade, B. S., Weener, M. E., Goes-Neto, A., Azevedo, V., Ghosh, P., Ganguly, N. K.
10.1101/2020.12.08.20245753 — Posted: 2020-12-09
SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany - a cross sectional study
Thielecke, M., Theuring, S., van Loon, W., Hommes, F., Mall, M. A., Rosen, A., Boehringer, F., von Kalle, C., Kirchberger, V., Kurth, T., Seybold, J., Mockenhaupt, F. P., BECOSS Study Group
10.1101/2020.12.08.20245910 — Posted: 2020-12-09
Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralisation and commercial assays
Bal, A., Trabaud, M.-A., Fassier, J.-B., Rabilloud, M., Saker, K., Langlois, C., Guibert, N., d'Aubarede, C., Paul, A., Alfaiate, D., Massardier, A., Pitiot, V., Morfin, F., Lina, B., Pozzetto, B., Trouillet-Assant, S.
10.1101/2020.12.08.20245811 — Posted: 2020-12-09
SARS Coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays
Walker, G. J., Naing, Z., Ospina Stella, A., Yeang, M., Caguicla, J., Ramachandran, V., Isaacs, S. R., Agapiou, D., Bull, R., Stelzer-Braid, S., Daly, J., Gosbell, I. B., Hoad, V. C., Irving, D. O., Pink, J. M., Turville, S., Kelleher, A. D., Rawlinson, W. D.
10.1101/2020.12.07.20245696 — Posted: 2020-12-09
Health Signatures During COVID-19: A Precision Fitness Case Study
Pollet, E. P., Sathish, A., Maloney, Z., Long, B. L., Brethen, J., Qutub, A. A.
10.1101/2020.12.07.20245001 — Posted: 2020-12-09
Characterising long-term covid-19: a rapid living systematic review
Michelen, M., Manoharan, L., Elkheir, N., Cheng, V., Dagens, D., Hastie, C., O'Hara, M., Suett, J., Burls, A., Foote, C., Carson, G., Olliaro, P. L., Sigfrid, L., Stavropoulou, C.
10.1101/2020.12.08.20246025 — Posted: 2020-12-09
Stress-related emotional and behavioural impact following the first COVID-19 outbreak peak
Benjamin, A., Kuperman, Y., Eren, N., Amitai, M., Rossman, H., Shilo, S., Meir, T., Keshet, A., Nuttman-Shwartz, O., Segal, E., Chen, A.
10.1101/2020.12.08.20245787 — Posted: 2020-12-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).